FDA approves first over-the-counter EKG product
The latest Apple Watch, known as Series 4, was unveiled today in California with numerous health-related implications.
Most headlines focused on the increased size of the watch—almost 30 percent bigger than its predecessor—but the overhauled software also includes a brand-new, built-in EKG scanner. The watch becomes the first over-the-counter EKG product ever offered directly to consumers.
By opening an App on the phone and placing your finger on the digital crown, users can trigger the EKG. The Apple Watch Series 4 has received clearance from the U.S. Food and Drug Administration (FDA)to be used as a medical device.
The watch’s main attraction—extended battery life—remains unchanged. The watch retains up to 18 hours of battery life per day, which allows for two full days on usage on average.
The new hardware also possesses the ability to detect falls, and trigger automatic 911 calls if an individual remains immobile for more than one minute following the fall.
Apple plans to make the Apple Watch Series 4 available to preorder this Friday, September 14, and it will ship on September 21, priced between $399–$499.